Sequential linezolid-resistant Staphylococcus epidermidis isolates with G2576T mutation

J Clin Microbiol. 2007 Oct;45(10):3277-80. doi: 10.1128/JCM.02048-06. Epub 2007 Aug 1.

Abstract

We report on an analysis of sequential isolates of Staphylococcus epidermidis from cultures of blood obtained from a patient with acute myeloid leukemia while the patient was receiving linezolid treatment. All 12 isolates had a linezolid MIC of 32 microg/ml. A 420-bp domain V region of the 23S rRNA gene from all isolates was amplified, and their nucleotide sequences were determined. A G2576T mutation was identified in all isolates. It was estimated that 67% of the 23S rRNA genes carried this mutation. This is the first report of the failure of linezolid treatment for Staphylococcus epidermidis bacteremia associated with a G2576T mutation in an immunocompromised patient.

Publication types

  • Case Reports

MeSH terms

  • Acetamides / pharmacology*
  • Aged
  • Anti-Infective Agents / pharmacology*
  • Bacteremia / microbiology
  • Drug Resistance, Bacterial
  • Humans
  • Linezolid
  • Male
  • Mutation*
  • Oxazolidinones / pharmacology*
  • RNA, Ribosomal, 23S / genetics
  • Staphylococcus epidermidis / drug effects*
  • Staphylococcus epidermidis / genetics

Substances

  • Acetamides
  • Anti-Infective Agents
  • Oxazolidinones
  • RNA, Ribosomal, 23S
  • Linezolid